Group One Trading’s iTeos Therapeutics ITOS Stock Holding History

Group One Trading’s Portfolio ITOS Stock Details ITOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-25,400	Closed	-$253K	–	8742
2025 Q2	$253K	Sell	25,400 -17,800	-41%	-$143K	﹤0.01%	4102
2025 Q1	$258K	Sell	43,200 -202,700	-82%	-$1.49M	﹤0.01%	3755
2024 Q4	$1.89M	Buy	245,900 +235,500	+2,264%	+$2.02M	﹤0.01%	1970
2024 Q3	$106K	Sell	10,400 -12,800	-55%	-$195K	﹤0.01%	4126
2024 Q2	$344K	Buy	23,200 +20,100	+648%	+$288K	﹤0.01%	2908
2024 Q1	$42.3K	Sell	3,100 -457,200	-99%	-$4.98M	﹤0.01%	4850
2023 Q4	$5.04M	Buy	460,300 +434,900	+1,712%	+$4.31M	0.01%	1133
2023 Q3	$278K	Buy	25,400 +21,500	+551%	+$275K	﹤0.01%	3506
2023 Q2	$51.6K	Sell	3,900 -16,400	-81%	-$234K	﹤0.01%	5249
2023 Q1	$276K	Buy	+20,300	New	+$364K	﹤0.01%	3363
2022 Q3	–	Sell	-10,400	Closed	-$214K	–	7853
2022 Q2	$214K	Buy	+10,400	New	+$247K	﹤0.01%	4243

Other funds holding ITOS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Group One Trading's ITOS Position: Q2 2025 in Review

Group One Trading sold out of iTeos Therapeutics (ITOS) in Q2 2025, closing a stake of 12,327 shares — an estimated $99.3K sold.

Group One Trading first reported a position in ITOS in Q2 2022 and held it in 8 quarters. The position peaked at $1M in Q4 2024. 136 funds tracked by Wall St. Rank hold ITOS as of Q2 2025.

Group One Trading reported no remaining iTeos Therapeutics position as of Q2 2025 after selling out during the quarter.
Group One Trading sold 12,327 iTeos Therapeutics shares in Q2 2025, an estimated $99.3K.
Group One Trading first reported a position in iTeos Therapeutics in Q2 2022 and held it in 8 quarters.
Group One Trading's iTeos Therapeutics position peaked at $1M in Q4 2024.
136 funds tracked by Wall St. Rank held iTeos Therapeutics as of Q2 2025.

Based on Group One Trading's 13F filing for Q2 2025, filed 14 Aug 2025.